Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer

PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer

US Patent 12144813 · Granted Nov 19, 2024

Estimated economic value: $3,187,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tumor grading and cancer prognosis2025
Post-treatment breast cancer prognosis2025
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic canc2025
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic canc2025
Cancer treatment using FGFR inhibitors and PLK1 inhibitors2024
Cancer treatment using FGFR inhibitors and PLK1 inhibitors2024
Neuroendocrine tumors2023
Identification of tumors and tissues2022
Post-treatment breast cancer prognosis2021
Tumor grading and cancer prognosis2021
Identification of tumors2020
Grading of breast cancer2019